Pharmacology was higher in early trading. As of press release, Pharmacology Juno-B (02126) rose 4.7% to HK$3.12; Pharmacology Biotech (02269) rose 5.27% to HK$31.95; Pharmacology Allied (02268) rose 4.37% to HK$28.65; and Pharmacology Kant (02359) rose 82.95 HK$82.95.
The Zhitong Finance App learned that Pharmacology was higher in early trading. As of press release, Pharmacology Juno-B (02126) rose 4.7% to HK$3.12; Pharmacology Biotech (02269) rose 5.27% to HK$31.95; Pharmacology Alliance (02268) rose 4.37% to HK$28.65; and Pharmacology and Conde (02359) rose 82.95 HK$82.95.
According to the news, the Joint Pharmaceutical Association stated that the Group's business operations have been carried out according to plan, and there have been no adverse changes. The company is confident about future development prospects and is currently unaware of any factors that may have a significant impact on business plans or growth goals.
Pharmaceutical Biotech, on the other hand, announced that the Company was allowed to repurchase up to about 425 million shares from the Hong Kong Stock Exchange, accounting for 10% of the total number of shares issued on the day of the Annual General Meeting of Shareholders. The board of directors of the Company hereby announces that on December 5, it resolved to use repurchase authorizations to repurchase shares on the open market from time to time at a total price of not more than US$600 million.